These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 16549404)

  • 21. [Medication for ADHD and the risk of cardiovascular mortality].
    Kalverdijk LJ; Buitelaar JK; van der Gaag RJ
    Ned Tijdschr Geneeskd; 2006 Oct; 150(41):2283-4; author reply 2284. PubMed ID: 17078147
    [No Abstract]   [Full Text] [Related]  

  • 22. ADHD black box warning: how concerned should we be?
    Cruz R; Kutscher EC
    S D Med; 2007 Feb; 60(2):63, 65. PubMed ID: 17390569
    [No Abstract]   [Full Text] [Related]  

  • 23. Clip & save: drug chart. FDA-approved drugs to treat ADHD.
    J Psychosoc Nurs Ment Health Serv; 2010 Mar; 48(3):9-10. PubMed ID: 20302260
    [No Abstract]   [Full Text] [Related]  

  • 24. Attention deficit hyperactivity disorder in prison.
    Ghanizadeh A; Akhondzadeh S
    J Am Acad Psychiatry Law; 2009; 37(2):278. PubMed ID: 19535565
    [No Abstract]   [Full Text] [Related]  

  • 25. What exactly are the benefits of stimulants for ADHD?
    Advokat C
    J Atten Disord; 2009 May; 12(6):495-8. PubMed ID: 19380518
    [No Abstract]   [Full Text] [Related]  

  • 26. Stimulant-drug therapy for attention-deficit disorder (with or without hyperactivity) and sudden cardiac death.
    Knight M
    Pediatrics; 2007 Jan; 119(1):154-5. PubMed ID: 17200281
    [No Abstract]   [Full Text] [Related]  

  • 27. ADHD drugs and cardiovascular risk.
    Wojnowski L
    N Engl J Med; 2006 May; 354(21):2296-8; author reply 2296-8. PubMed ID: 16729376
    [No Abstract]   [Full Text] [Related]  

  • 28. Attention-deficit hyperactivity disorder (ADHD) treatment and sudden death.
    Besag FM
    Drug Saf; 2009; 32(11):1097-100. PubMed ID: 19810781
    [No Abstract]   [Full Text] [Related]  

  • 29. FDA issues public health advisory on phenylpropanolamine in drug products.
    Meadows M
    FDA Consum; 2001; 35(1):9. PubMed ID: 11930934
    [No Abstract]   [Full Text] [Related]  

  • 30. Encouraging news about ADHD drugs and heart risk in adults.
    Harv Ment Health Lett; 2012 Mar; 28(9):7. PubMed ID: 22474711
    [No Abstract]   [Full Text] [Related]  

  • 31. American Society for Clinical Pharmacology and Therapeutics position statement on the public health risks of ephedra.
    Hollister AS; Kearns GL
    Clin Pharmacol Ther; 2003 Nov; 74(5):403-5. PubMed ID: 14586380
    [No Abstract]   [Full Text] [Related]  

  • 32. Pre-existing cardiovascular conditions and pharmacological treatment of adult ADHD.
    Gerhard T; Winterstein AG; Olfson M; Huang C; Saidi A; Crystal S
    Pharmacoepidemiol Drug Saf; 2010 May; 19(5):457-64. PubMed ID: 20232490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health state utilities for childhood attention-deficit/hyperactivity disorder based on parent preferences in the United kingdom.
    Secnik K; Matza LS; Cottrell S; Edgell E; Tilden D; Mannix S
    Med Decis Making; 2005; 25(1):56-70. PubMed ID: 15673582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Addictive drugs still best option for attention deficit disorder.
    Basu P
    Nat Med; 2006 Apr; 12(4):374. PubMed ID: 16598272
    [No Abstract]   [Full Text] [Related]  

  • 35. Stimulant use linked to sudden death in children without heart problems.
    Kuehn BM
    JAMA; 2009 Aug; 302(6):613-4. PubMed ID: 19671894
    [No Abstract]   [Full Text] [Related]  

  • 36. Methylphenidate transdermal system.
    Mays DA; Findling R
    J Am Acad Child Adolesc Psychiatry; 2005 Dec; 44(12):1223. PubMed ID: 16292112
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing.
    Vetter VL; Elia J; Erickson C; Berger S; Blum N; Uzark K; Webb CL; ;
    Circulation; 2008 May; 117(18):2407-23. PubMed ID: 18427125
    [No Abstract]   [Full Text] [Related]  

  • 38. A reply to critics of using stimulants to treat attention deficit hyperactivity disorder.
    Pliszka SR
    Tex Med; 1991 Apr; 87(4):84-7. PubMed ID: 1674631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drugs and children.
    Pinkham JR
    ASDC J Dent Child; 2002; 69(1):10. PubMed ID: 12119805
    [No Abstract]   [Full Text] [Related]  

  • 40. Pemoline in ADHD.
    Winsberg B; Barbato M
    J Am Acad Child Adolesc Psychiatry; 1997 Dec; 36(12):1649-50. PubMed ID: 9401321
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.